FDA Inspection 1177194 — Pedro Mendes Bastos, MD
The FDA completed an inspection of Pedro Mendes Bastos, MD on Jun 23, 2022 in Lisbon. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 23, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lisbon (Portugal)
Additional Details
Clinical Investigator (CI)